Skip to main content
. Author manuscript; available in PMC: 2024 May 30.
Published in final edited form as: Nurse Educ Today. 2023 Jun 14;128:105873. doi: 10.1016/j.nedt.2023.105873

Table 3.

Provider Knowledge by Cadre

N, %
CM Cause *Fungus
Medical Officers 5, 100
Clinical Officers 6, 85.7
Nurse 1, 12.5
CM Transmission *Airborne
Medical Officers 4, 80
Clinical Officers 3, 42.9
Nurse 4, 50
Who is susceptible to CM?
*Immunocompromised 20, 100
Length of CM maintenance treatment: *CD4 ≥200
Medical Officers 2, 75
Clinical Officers 1, 14.3
Nurse 0, 0
What CD4 is used to screen for CM: *CD4 ≤200
Medical Officers 2, 40
Clinical Officers 4, 57.1
Nurse 1, 12.5
What treatment do you give most often for CM: *Ampho B and Fluconazole
Medical Officers 3, 60
Clinical Officers 2, 28.6
Nurse 0, 0
Amphotericin B is available
Medical Officers 3, 60
Clinical Officers 3, 42.9
Nurse 1, 12.5
What do you need to diagnose CM more accurately?
India Ink
Medical Officers 1, 20
Clinical Officers 1, 14.3
Nurse 3, 37.5
* CSF/Lumbar Puncture
Medical Officers 1, 20
Clinical Officers 2, 28.6
Nurse 0, 0
* CrAg Test
Medical Officers 0, 0
Clinical Officers 2, 28.6
Nurse 0, 0
* CSF Culture
Medical Officers 3, 60
Clinical Officers 3, 42.9
Nurse 0, 0
Blood Culture
Medical Officers 0, 0
Clinical Officers 0, 0
Nurse 2, 25
I Don’t know
Medical Officers 0, 0
Clinical Officers 0, 0
Nurse 1, 20
*

Denotes correct answer